Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Recent Roche patent describes new NNRTIs for HIV infection

Feb. 3, 2009

New HIV RT inhibitors jointly developed by Gilead & Korea Research Institute of Chemical Technology

Feb. 2, 2009

Priming with rAd41 vector expressing HIV Env facilitates mucosal immunity in mice

Jan. 28, 2009

New non-nucleoside reverse transcriptase inhibitors in development at GSK

Jan. 28, 2009

Myriad acquires Panacos' HIV drug bevirimat

Jan. 23, 2009

New reverse transcriptase inhibitors for HIV presented in recent GSK patent

Jan. 21, 2009

Janssen Pharma launches HIV drug Intelence in Japan

Jan. 20, 2009

New non-nucleoside reverse transcriptase inhibitors prepared and tested at GSK

Jan. 16, 2009

Esteve signs research partnership for development of AIDS vaccine

Jan. 14, 2009

Celsentri tablets approved in Japan for HIV

Dec. 31, 2008

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026